Search Results - "KIM, Jenny J"

Comparative Analysis of Dorsal Root, Nodose and Sympathetic Ganglia for the Development of New Analgesics by Sapio, Matthew R, Vazquez, Fernando A, Loydpierson, Amelia J, Maric, Dragan, Kim, Jenny J, LaPaglia, Danielle M, Puhl, Henry L, Lu, Van B, Ikeda, Stephen R, Mannes, Andrew J, Iadarola, Michael J

“…Interoceptive and exteroceptive signals, and the corresponding coordinated control of internal organs and sensory functions, including pain, are received and…”
Get full text

Transcriptional Activation, Deactivation and Rebound Patterns in Cortex, Hippocampus and Amygdala in Response to Ketamine Infusion in Rats by Kim, Jenny J, Sapio, Matthew R, Vazquez, Fernando A, Maric, Dragan, Loydpierson, Amelia J, Ma, Wenting, Zarate, Jr, Carlos A, Iadarola, Michael J, Mannes, Andrew J

“…Ketamine, an -methyl-D-aspartate (NMDA)-receptor antagonist, is a recently revitalized treatment for pain and depression, yet its actions at the molecular…”
Get full text

Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas by SCHULTZ, Luciana, CHAUX, Alcides, ARGANI, Pedram, REUTER, Victor E, NETTO, George J, ALBADINE, Roula, HICKS, Jessica, KIM, Jenny J, DE MARZO, Angelo M, ALLAF, Mohamad E, CARDUCCI, Michael A, RODRIGUEZ, Ronald, HAMMERS, Hans-Joerg

“…The need for effective targeted therapies for renal cell carcinomas (RCCs) has fueled the interest for understanding molecular pathways involved in the…”
Get full text

Proteolytic Exposure of a Cryptic Site within Collagen Type IV Is Required for Angiogenesis and Tumor Growth in vivo by Xu, Jingsong, Rodriguez, Dorothy, Petitclerc, Eric, Kim, Jenny J., Hangai, Masanori, Yuen, S. Moon, Davis, George E., Brooks, Peter C.

“…Evidence is provided that proteolytic cleavage of collagen type IV results in the exposure of a functionally important cryptic site hidden within its triple…”
Get full text

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma by Chesney, Jason, Puzanov, Igor, Collichio, Frances, Singh, Parminder, Milhem, Mohammed M, Glaspy, John, Hamid, Omid, Ross, Merrick, Friedlander, Philip, Garbe, Claus, Logan, Theodore F, Hauschild, Axel, Lebbé, Celeste, Chen, Lisa, Kim, Jenny J, Gansert, Jennifer, Andtbacka, Robert H I, Kaufman, Howard L

“…Purpose We evaluated the combination of talimogene laherparepvec plus ipilimumab versus ipilimumab alone in patients with advanced melanoma in a phase II…”
Get full text

Explaining the Multiple Populations in Globular Clusters by Multiple Episodes of Star Formation and Enrichment without Gas Expulsion from Massive Star Feedback by Kim, Jenny J., Lee, Young-Wook

“…In order to investigate the origin of multiple stellar populations found in globular clusters (GCs) in the halo and bulge of the Milky Way, we have constructed…”
Get full text

Telaprevir: An oral protease inhibitor for hepatitis C virus infection by Kim, Jenny J, Culley, Colleen M, Mohammad, Rima A

“…The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, drug interactions, viral drug resistance, dosage and administration, and place…”
Get full text

Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas by Chaux, Alcides, MD, Schultz, Luciana, MD, Albadine, Roula, MD, Hicks, Jessica, MS, Kim, Jenny J., MD, Allaf, Mohamad E., MD, Carducci, Michael A., MD, Rodriguez, Ronald, MD, Hammers, Hans-Joerg, MD, Argani, Pedram, MD, Reuter, Victor E., MD, Netto, George J., MD

“…Summary Dysregulation of the mammalian target of rapamycin and hypoxia-induced pathways has been consistently identified in clear cell renal cell carcinomas…”
Get full text

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial by Locke, Frederick L, Ghobadi, Armin, Jacobson, Caron A, Miklos, David B, Lekakis, Lazaros J, Oluwole, Olalekan O, Lin, Yi, Braunschweig, Ira, Hill, Brian T, Timmerman, John M, Deol, Abhinav, Reagan, Patrick M, Stiff, Patrick, Flinn, Ian W, Farooq, Umar, Goy, Andre, McSweeney, Peter A, Munoz, Javier, Siddiqi, Tanya, Chavez, Julio C, Herrera, Alex F, Bartlett, Nancy L, Wiezorek, Jeffrey S, Navale, Lynn, Xue, Allen, Jiang, Yizhou, Bot, Adrian, Rossi, John M, Kim, Jenny J, Go, William Y, Neelapu, Sattva S

“…Axicabtagene ciloleucel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. In the previous analysis of the ZUMA-1 registrational study,…”
Get full text

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma by Neelapu, Sattva S., Jacobson, Caron A., Oluwole, Olalekan O., Munoz, Javier, Deol, Abhinav, Miklos, David B., Bartlett, Nancy L., Braunschweig, Ira, Jiang, Yizhou, Kim, Jenny J., Zheng, Lianqing, Rossi, John M., Locke, Frederick L.

“…Neelapu and colleagues report a post hoc subgroup analysis from the ZUMA-1 trial of chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse…”
Get full text

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma by Scholler, Nathalie, Perbost, Regis, Locke, Frederick L., Jain, Michael D., Turcan, Sarah, Danan, Corinne, Chang, Edmund C., Neelapu, Sattva S., Miklos, David B., Jacobson, Caron A., Lekakis, Lazaros J., Lin, Yi, Ghobadi, Armin, Kim, Jenny J., Chou, Justin, Plaks, Vicki, Wang, Zixing, Xue, Allen, Mattie, Mike, Rossi, John M., Bot, Adrian, Galon, Jérôme

“…Axicabtagene ciloleucel (axi-cel) is an anti-CD19 chimeric antigen receptor (CAR) T cell therapy approved for relapsed/refractory large B cell lymphoma (LBCL)…”
Get full text

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma by Neelapu, Sattva S., Jacobson, Caron A., Ghobadi, Armin, Miklos, David B., Lekakis, Lazaros J., Oluwole, Olalekan O., Lin, Yi, Braunschweig, Ira, Hill, Brian T., Timmerman, John M., Deol, Abhinav, Reagan, Patrick M., Stiff, Patrick, Flinn, Ian W., Farooq, Umar, Goy, Andre H., McSweeney, Peter A., Munoz, Javier, Siddiqi, Tanya, Chavez, Julio C., Herrera, Alex F., Bartlett, Nancy L., Bot, Adrian A., Shen, Rhine R., Dong, Jinghui, Singh, Kanwarjit, Miao, Harry, Kim, Jenny J., Zheng, Yan, Locke, Frederick L.

“…•Axicabtagene ciloleucel induced long-term survival with no new safety signals in patients with refractory LBCL.•Durable responses were associated with…”
Get full text

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma by Oluwole, Olalekan O., Bouabdallah, Krimo, Muñoz, Javier, De Guibert, Sophie, Vose, Julie M., Bartlett, Nancy L., Lin, Yi, Deol, Abhinav, McSweeney, Peter A., Goy, Andre H., Kersten, Marie José, Jacobson, Caron A., Farooq, Umar, Minnema, Monique C., Thieblemont, Catherine, Timmerman, John M., Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Kim, Jenny J., Bashir, Zahid, McLeroy, Jeff, Zheng, Yan, Rossi, John M., Johnson, Lisa, Goyal, Lovely, Meerten, Tom

“…Summary ZUMA‐1 (NCT02348216) examined the safety and efficacy of axicabtagene ciloleucel (axi‐cel), an autologous CD19‐directed chimaeric antigen receptor…”
Get full text

Multiple Populations in Globular Clusters: Unified Efforts from Stellar Evolution and Chemical Evolution Models by Jang, Sohee, Kim, Jenny J., Lee, Young-Wook

“…Recent stellar evolution models for globular clusters (GCs) in a multiple population paradigm suggest that horizontal-branch (HB) morphology and the mean…”
Get full text

Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium by Heng, Daniel Y.C, Wells, J. Connor, Rini, Brian I, Beuselinck, Benoit, Lee, Jae-Lyun, Knox, Jennifer J, Bjarnason, Georg A, Pal, Sumanta Kumar, Kollmannsberger, Christian K, Yuasa, Takeshi, Srinivas, Sandy, Donskov, Frede, Bamias, Aristotelis, Wood, Lori A, Ernst, D. Scott, Agarwal, Neeraj, Vaishampayan, Ulka N, Rha, Sun Young, Kim, Jenny J, Choueiri, Toni K

“…Abstract Background The benefit of cytoreductive nephrectomy (CN) for overall survival (OS) is unclear in patients with synchronous metastatic renal cell…”
Get full text

Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma by Topp, Max S., Meerten, Tom, Houot, Roch, Minnema, Monique C., Bouabdallah, Krimo, Lugtenburg, Pieternella J., Thieblemont, Catherine, Wermke, Martin, Song, Kevin W., Avivi, Irit, Kuruvilla, John, Dührsen, Ulrich, Zheng, Yan, Vardhanabhuti, Saran, Dong, Jinghui, Bot, Adrian, Rossi, John M., Plaks, Vicki, Sherman, Marika, Kim, Jenny J., Kerber, Anne, Kersten, Marie José

“…Summary Axicabtagene ciloleucel (axi‐cel) is an autologous anti‐CD19 chimeric antigen receptor (CAR) T‐cell therapy approved for relapsed or refractory large…”
Get full text

Measuring the mixing scale of the ISM within nearby spiral galaxies by Kreckel, Kathryn, Ho, I-Ting, Blanc, Guillermo A, Glover, Simon C O, Groves, Brent, Rosolowsky, Erik, Bigiel, Frank, Boquíen, Médéric, Chevance, Mélanie, Dale, Daniel A, Deger, Sinan, Emsellem, Eric, Grasha, Kathryn, Kim, Jenny J, Klessen, Ralf S, Kruijssen, J M Diederik, Lee, Janice C, Leroy, Adam K, Liu, Daizhong, McElroy, Rebecca, Meidt, Sharon E, Pessa, Ismael, Sanchez-Blazquez, Patricia, Sandstrom, Karin, Santoro, Francesco, Scheuermann, Fabian, Schinnerer, Eva, Schruba, Andreas, Utomo, Dyas, Watkins, Elizabeth J, Williams, Thomas G

“…ABSTRACT The spatial distribution of metals reflects, and can be used to constrain, the processes of chemical enrichment and mixing. Using PHANGS-MUSE optical…”
Get full text

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib? by Keizman, Daniel, Rouvinov, Keren, Sella, Avishay, Gottfried, Maya, Maimon, Natalie, Kim, Jenny J, Eisenberger, Mario A, Sinibaldi, Victoria, Peer, Avivit, Carducci, Michael A, Mermershtain, Wilmosh, Leibowitz-Amit, Raya, Weitzen, Rony, Berger, Raanan

“…Studies suggested the existence of a 'trial effect', in which for a given treatment, participation in a clinical trial is associated with a better outcome…”
Get full text

Axicabtagene Ciloleucel in Combination With the 4-1BB Agonist Utomilumab in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results From ZUMA-11 by Jain, Michael D, Miklos, David B, Jacobson, Caron A, Timmerman, John M, Sun, Jennifer, Nater, Jenny, Fang, Xiang, Patel, Ankit, Davis, Madison, Heeke, Darren, Trinh, Tan, Mattie, Mike, Neumann, Frank, Kim, Jenny J, To, Christina, Filosto, Simone, Reshef, Ran

“…Chimeric antigen receptor (CAR) T-cell therapies have shown clinical benefit for patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL), yet…”
Get full text

Community pharmacist intervention to close statin gaps in diabetes care: The GuIDE-S study by Bacci, Jennifer L., Rodriguez, Tricia, Hansen, Ryan, Marcum, Zachary A., Bansal, Aasthaa, Pfund, Tara, Kim, Jenny J., Odegard, Peggy

“…Statin therapy is recommended for people with type 2 diabetes (T2D) to lower cardiovascular risk; however, evidence suggests that significant gaps in statin…”
Get full text